Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Madhav Lavu"'
Publikováno v:
Indian Pacing and Electrophysiology Journal, Vol 15, Iss 6, Pp 293-295 (2015)
Although current lead design and filtering capabilities have greatly improved, Electromagnetic Interference (EMI) from environmental sources has been increasingly reported in patients with Cardiac Implantable Electronic Device (CIED) [1]. Few cases o
Externí odkaz:
https://doaj.org/article/c5ddbbb842db493e83ce86aafc444abe
Autor:
Seth H. Sheldon, Ryan Cunnane, Valay Parikh, Donita Atkins, Raghuveer Dendi, Rhea Pimentel, Martin Emert, Loren Berenbom, Dhanunjaya Lakkireddy, Yeruva Madhu Reddy, Madhav Lavu
Publikováno v:
Pacing and Clinical Electrophysiology. 41:799-806
BACKGROUND The safety of perioperative anticoagulation (AC) and antiplatelet (AP) therapy with subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation is unknown. The purpose of this study was to identify the risk factors associated
Autor:
Valay Parikh, Madhav Lavu, Venkat Vuddanda, Mohit K. Turagam, Mojtaba Olyaee, Donita Atkins, Vijay Swarup, Luigi Di Biase, Mohammad-Ali Jazayeri, Dhanunjaya Lakkireddy, Madhu Reddy Yeruva, Rakesh Gopinathannair, Andrea Natale, Sudharani Bommana, Jie Cheng, Vijay Ivaturi
Publikováno v:
JACC: Clinical Electrophysiology. 3:1390-1399
Objectives The present study describes the use of octreotide (OCT) in patients with atrial fibrillation (AF) receiving oral anticoagulation (OAC) who have gastrointestinal (GI) bleeding related to arteriovenous malformations (AVMs), as well as its ef
Autor:
Andrea Natale, Madhav Lavu, Madhu Reddy, James L. Vacek, Donita Atkins, Dhanunjaya Lakkireddy, Jayasree Pillarisetti, Courtney Jeffrey, Mohit K. Turagam, Jodi Hurwitz, Katie Christensen, Muhammad R. Afzal, Luigi Di Biase, Raghuveer Dendi, Rhea Pimentel
Publikováno v:
International Journal of Cardiology. 236:221-225
Dofetilide is a class III antiarrhythmic drug that has been reported to be safe and efficacious in the treatment of atrial dysrhythmias with a known initial risk of QT prolongation and torsades de pointes (TdP). As a result, the Federal Drug Administ
Autor:
Donita Atkins, Dhanunjaya Lakkireddy, Buddhadeb Dawn, Rizwan Afzal, Arun Raghav Mahankali Sridhar, Vivek Yarlagadda, Madhav Lavu, Madhu Reddy, Sampath Gunda, Rakesh Gopinathanair
Publikováno v:
Pacing and Clinical Electrophysiology. 40:286-293
BACKGROUND Implantation of cardiac implanted electronic device (CIED) has surged lately. This resulted in a rise in cardiac device-related infections (CDI) and inevitably, lead extractions. We examined the recent national trend in the incidence of CI
Autor:
Mohammad-Ali Jazayeri, Rodney Horton, Madhav Lavu, Rong Bai, Valay Parikh, Donita Atkins, Sudharani Bommana, Muhammad R. Afzal, Dhanunjaya Lakkireddy, Jie Cheng, Venkat Vuddanda, Mohit K. Turagam, Andrea Natale, Vijay Swarup, Luigi Di Biase
Publikováno v:
Journal of Cardiovascular Electrophysiology. 28:139-146
Background There have been an increasing number of atrial fibrillation (AF) patients with Watchman® left atrial appendage occlusion (LAAO) device, requiring catheter ablation (CA) for maintenance of normal sinus rhythm. In this study, we describe ou
Autor:
Mohammad-Ali Jazayeri, Valay Parikh, Venkat Vuddanda, Madhav Lavu, Y. Madhu Reddy, Donita Atkins, Dhanunjaya Lakkireddy, Jayant Nath
Publikováno v:
Journal of Thoracic Disease. 8:E1726-E1733
Left atrial appendage closure (LAAC) is a promising site-directed therapy for stroke prevention in patients with non-valvular atrial fibrillation (AF) who are ineligible or contraindicated for long-term oral anticoagulation. A variety of LAAC modalit
Publikováno v:
Journal of Innovations in Cardiac Rhythm Management. 7:2378-2386
Autor:
Tawseef Dar, Venkat Vuddanda, Mohit K. Turagam, Madhav Lavu, Donita Atkins, Sindhu Avula, Valay Parikh, Sudharani Bommana, Rakesh Gopinathannair, Dhanunjaya Lakkireddy, Madhu Reddy Yeruva, Bharath Yarlagadda, Mohammad-Ali Jazayeri
Publikováno v:
Scopus-Elsevier
Background: We sought to investigate and compare the safety and efficacy of two commonly used antiarrhythmic drugs, Dofetilide (DF) and Sotalol (SL), during inpatient drug initiation in patients with symptomatic atrial fibrillation (AF). Methods: We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a017c1442e93247de940940e4456f3f
https://europepmc.org/articles/PMC5821637/
https://europepmc.org/articles/PMC5821637/
Autor:
Mohammad-Ali Jazayeri, Venkat Vuddanda, Jaya Pitchika, Mounika Gangireddy, Saisree Reddy Adla Jala, Madhav Lavu, Valay Parikh, Mohit K Turagam, Sudharani Bommana, Donita Atkins, Rhaguveer Dendi, Martin P Emert, Rhea C Pimentel, Seth H Sheldon, Loren Berenbom, Dhanunjaya R Lakkireddy, Madhu Reddy
Publikováno v:
Circulation. 136
Introduction: Radiofrequency catheter ablation (RFCA), an effective treatment for atrial fibrillation (AF), is rarely complicated by severe pulmonary vein stenosis (PVS) requiring intervention. We sought to evaluate the safety of repeat RFCA in AF pa